Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Non-Hodgkin's lymphoma (NHL) is a heterogeneous group of lymphoid malignancies.
• Leukemic transformation, or leukemic phase, is a known complication in some NHL subtypes.
• Peripheral blood involvement is a clinical indicator that may affect prognosis.

Purpose of the Study:

• To investigate the significance of peripheral blood involvement in various non-Hodgkin's lymphoma subtypes.
• To analyze the clinical implications and prognostic impact of leukemic transformation across different NHL histologic classifications.
• To identify specific NHL subtypes with a high risk of leukemic conversion.

Main Methods:

• Patients with non-Hodgkin's lymphoma were classified using a modified Rappaport classification.
• Peripheral blood involvement was assessed in relation to histologic subtypes.
• Leukemic survival and prognostic factors were analyzed for each subtype.

Main Results:

• Leukemic phase occurred in 14% of 214 patients.
• Two distinct subtypes of nodular lymphoma, poorly differentiated lymphocytic lymphoma (NPDL) were identified, one with lymphoblastoid features and a median leukemic survival of 2 months.
• Conventional NPDL had a median leukemic survival of 43+ months; diffuse large cell lymphomas had a median leukemic survival of 0.5 months, with peripheral blood involvement as a terminal event.
• Adult lymphoblastic lymphoma showed a 100% risk of leukemic conversion.

Conclusions:

• Peripheral blood involvement is a significant prognostic indicator in specific non-Hodgkin's lymphoma subtypes.
• Distinct clinicopathologic entities, such as adult lymphoblastic lymphoma and a lymphoblastoid variant of NPDL, are associated with a high risk of leukemic transformation and poor survival.
• Accurate subtyping of NHL is essential for predicting leukemic potential and guiding patient management.